Investors with any experience in the world of penny stocks know that risk is real. That risk is higher as the price of shares goes lower. Thus, stocks trading between $5 and $10 are somewhat more stable than their sub-$5 counterparts. Stocks in the $5 to $10 price range have generally passed major tests and become more stable in the process. That's true of all of the shares discussed below. These shares also appear to be poised for breakouts moving forward. Furthermore, all of the stocks discussed below hav ...

Warchi I have recently added a quarter position of Acacia Research (NASDAQ:ACTG) to my value portfolio and will use any dips to add shares until I have a half portfolio position. Acacia Research is a type of BDC (business development company) which seeks to acquire, manage, and eventually sell off small to mid-sized (<$1B) companies in the industrial, energy, technology, and healthcare verticals. It is majority (61%) owned and influenced by Starboard Value LP, an investment adviser (see their website an ...

Finding great opportunities in the middle of market swings is a never-ending task in the dynamic world of stock investing. These three stocks, all under $5, are ripe for a dramatic climb and have the potential to develop significantly. The gold industry, healthcare technology, and specialty finance all present prospects for the stocks. By making smart acquisitions in the oil and gas industry, the first one aims to increase its income sources strategically. The firm demonstrates scalability and a diversified ...

Acacia Research Corporation (NASDAQ:ACTG) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Rob Fink - FNK, IR MJ McNulty - CEO Kirsten Hoover - Interim CFO Conference Call Participants Brett Reiss - Janney Montgomery Scott Adam Eagleston - Formidable Asset Management Operator Good day and welcome to the Acacia Research First Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode. After managements prepared remarks there will be a q ...

Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ______________ Commission file number: 001-37721 Acacia Research Corporation (Name of registrant as specified in its charter) Delaware 95-4405754 (Stat ...

Revenue and Financial Performance - Total revenues for Q1 2024 were $24.3 million, a significant increase from $14.8 million in Q1 2023, driven by $13.6 million from intellectual property operations[2][4] - Total revenues for Q1 2024 were $24,320 thousand, a significant increase from $14,803 thousand in Q1 2023[17] - Intellectual property operations revenue grew to $13,623 thousand in Q1 2024, compared to $4,176 thousand in Q1 2023[17] - Industrial operations revenue decreased to $8,841 thousand in Q1 2024 from $10,627 thousand in Q1 2023[17] - Energy operations generated $1,856 thousand in revenue in Q1 2024, a new segment not present in Q1 2023[17] - Benchmark Energy generated $1.9 million in revenue in Q1 2024, with no comparable revenue in Q1 2023[2][5] Net Income and Loss - GAAP net loss for Q1 2024 was $0.2 million, or $0.00 per share, compared to a net income of $9.4 million in Q1 2023[2][4] - Net loss attributable to Acacia Research Corporation was $186 thousand in Q1 2024, compared to a net income of $9,447 thousand in Q1 2023[17] - Operating loss improved to $2,087 thousand in Q1 2024 from $9,324 thousand in Q1 2023[17] Cash and Investments - Acacia holds $461.7 million in cash, cash equivalents, and equity investments as of March 31, 2024, up from $403.2 million at the end of 2023[8] - The company has $400 million in cash and marketable securities, net of cash deployed in Benchmark's recent acquisition[1] - Cash and cash equivalents increased to $438,762 thousand as of March 31, 2024, up from $340,091 thousand at the end of 2023[16] Asset and Equity Changes - Book value per share at March 31, 2024 was $5.89, or $5.95 excluding a $6.2 million accrual related to the AIP Matter[2][9] - Accounts receivable decreased to $15,372 thousand as of March 31, 2024, down from $80,555 thousand at the end of 2023[16] - Total assets slightly decreased to $631,725 thousand as of March 31, 2024, from $633,545 thousand at the end of 2023[16] - Equity securities investments showed a change in fair value of $26,701 thousand loss in Q1 2024, compared to a $3,343 thousand gain in Q1 2023[17] Acquisitions and Divestitures - The company completed the sale of Arix Bioscience Plc shares for $57.1 million, realizing a gain of $28.6 million[2] - Benchmark's recent acquisition added 140,000 net acres and 470 operated producing wells in the Western Anadarko Basin[2] Expenses - General and administrative expenses increased to $12.4 million in Q1 2024, up from $12.0 million in Q1 2023[5] Life Sciences Portfolio - Acacia's life sciences portfolio has generated $564.1 million in proceeds from sales and royalties, with remaining positions valued at $25.7 million[7]

Acacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Conference Call March 14, 2024 4:30 PM ET Company Participants Rob Fink - FNK, Investor Relations MJ McNulty - Chief Executive Officer Kirsten Hoover - Interim Chief Financial Officer Conference Call Participants Anthony Stoss - Craig-Hallum Brett Reiss - Janney Montgomery Scott Operator Good afternoon, everyone. And welcome to the Acacia Research Fourth Quarter and Year End 2023 Financial Results Call. At this time, all participants are in a listen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________________ FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ___________TO ___________. Commission File Number 001-37721 ______________________ (Exact name of registrant as specified in its charter) Delaware 95-4 ...

Exhibit 99.1 Acacia Research Reports Fourth Quarter 2023 Financial Results Intellectual Property Licensing and Settlement Agreements Drive Q4 Income; Company Continues to Advance Capital Allocation and Business Strategy, Announced Agreement to Acquire Cash Flow-Generating Oil and Gas Assets with a Goal of Driving Book Value per Share New York, NY, March 14, 2024 - Acacia Research Corporation (Nasdaq: ACTG) (“Acacia” or the “Company”) today reported financial results for the three months and full year ended ...

NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) today announced an agreement related to its intellectual property business. Atlas Global Technologies LLC (“AGT”), a subsidiary of Acacia Research Group LLC (the patent licensing business of Acacia Research Corporation), entered into licensing and settlement agreements relating to its WiFi-6 patent portfolio during the fourth quarter of 2023, with aggregate payments under such agreements totaling more than $81 million. The details of suc ...